Dr Reddy's Laboratories rose 1.25% to Rs 3,421.65 at 09:42 IST on BSE after the company launched HAiROOTZ, the first hair growth supplement to be marketed in India as over-the-counter by the company.
The announcement was made after market hours on Friday, 19 June 2015.
Meanwhile, the BSE Sensex was up 207.54 points, or 0.76%, to 27,523.71
On BSE, so far 1,899 shares were traded in the counter, compared with an average volume of 26,873 shares in the past one quarter.
The stock hit a high of Rs 3,422.40 and a low of Rs 3,405.15 so far during the day. The stock hit a 52-week high of Rs 3,808.75 on 10 April 2015. The stock hit a 52-week low of Rs 2,419 on 19 June 2014.
The large-cap pharma firm has equity capital of Rs 85.25 crore. Face value per share is Rs 5.
More From This Section
Dr Reddy's Laboratories HAiROOTZ comes from the same branch of business that markets MINTOPTM, the No. 1 dermatologist recommended brand in the country.
Dr Reddy's Laboratories' consolidated net profit rose 7.7% to Rs 518.84 crore on 10.8% growth in total income to Rs 3887.34 crore in Q4 March 2015 over Q4 March 2014.
Dr Reddy's Laboratories is an integrated global pharmaceutical company. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Powered by Capital Market - Live News